Mark Bustoros

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Mark Bustoros

Jan 4, 2025, 10:44 | Science

Myeloma Paper of the Day, January 4th, suggested by Robert Orlowski

Robert Orlowski shared a post on X: "Myeloma Paper of the Day: I-PRISM phase II of…

Oct 21, 2024, 12:43 | Blog

Mark Bustoros: Great debate about whether CAR-T could replace autotransplant as consolidation

Mark Bustoros, Physician-scientist, Assistant Professor at Weill Cornell Medicine, shared on X: ''Great debate and overview…

Oct 20, 2024, 09:50 | Positive

4th Annual IMS Translational Research Award Winners: Part 1

The International Myeloma Society (IMS) and the Paula and Rodger Riney Foundation have announced the fourth annual IMS Translational Research…

Aug 12, 2024, 03:20 | Blog

Using lymphocyte count to predict CAR-T cell therapy efficacy in relapsed multiple myeloma

WCM Myeloma Center posted on X: "New research led by Drs. Mateo Mejia, Ruben Niesvizky…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023